Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1992;71:27-33

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chapman, G. D.
Right arrow Articles by Stack, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chapman, G. D.
Right arrow Articles by Stack, R. S.

Circulation Research, Vol 71, 27-33, Copyright © 1992 by American Heart Association


ARTICLES

Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter

GD Chapman, CS Lim, RS Gammon, SC Culp, JS Desper, RP Bauman, JL Swain and RS Stack
Department of Medicine, Duke University Medical Center, Durham, N.C.

Genetic manipulation of the vasculature may offer insights into the pathogenesis of coronary artery disease and may lead to gene therapy for disorders such as restenosis after percutaneous coronary angioplasty. The goal of this study was to develop a percutaneous method for gene transfer into coronary arteries of intact animals. Liposomes were used to facilitate transfection in coronary arteries with a plasmid containing the cDNA encoding luciferase. This reporter was chosen since it is not expressed in mammalian cells, and it can be quantified using a sensitive assay (light production). Mongrel dogs were catheterized, and DNA was delivered to coronary arteries via a porous perfusion balloon system. Luciferase expression was measured 3-5 days after the procedure, when the dogs were killed. Luciferase activity in control arteries (n = 12) was no higher than average background activity. Eight of 12 transfected arteries exhibited gene expression, averaging 4.3 +/- 2.1 pg luciferase (p less than 0.01, transfected versus control arteries). In addition, the ability to transfect DNA into femoral arteries without a transfection vehicle was tested. Five dogs were subjected to surgical transfection attempts in their femoral arteries with either DNA alone or DNA plus liposomes. Luciferase was expressed in all 10 femoral arteries; those treated with DNA alone expressed 35.6 +/- 8 pg luciferase, and those treated with DNA plus liposomes expressed 42.3 +/- 14 pg luciferase (p = 0.70). These results demonstrate the use of a percutaneous catheter to achieve gene transfer and expression in coronary arteries of intact dogs and suggest that the efficiency of intra-arterial gene transfer may be similar whether or not a transfection vehicle is used.


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
F. Sharif, K. Daly, J. Crowley, and T. O'Brien
Current status of catheter- and stent-based gene therapy
Cardiovasc Res, November 1, 2004; 64(2): 208 - 216.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Hayashi, D. Sumi, P. A.R Juliet, H. Matsui-Hirai, Y. Asai-Tanaka, H. Kano, A. Fukatsu, T. Tsunekawa, A. Miyazaki, A. Iguchi, et al.
Gene transfer of endothelial NO synthase, but not eNOS, plus inducible NOS regressed atherosclerosis in rabbits
Cardiovasc Res, February 1, 2004; 61(2): 339 - 351.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Ooboshi, S. Ibayashi, J. Takada, H. Yao, T. Kitazono, and M. Fujishima
Adenovirus-Mediated Gene Transfer to Ischemic Brain : Ischemic Flow Threshold for Transgene Expression
Stroke, April 1, 2001; 32(4): 1043 - 1047.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
S. L. Meyerson, C. L. Skelly, M. A. Curi, and L. B. Schwartz
Gene Therapy for Cardiovascular Disease
Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2000; 4(4): 289 - 300.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
K. Morishige, H. Shimokawa, T. Yamawaki, K. Miyata, Y. Eto, T. Kandabashi, K. Yogo, T. Higo, K. Egashira, H. Ueno, et al.
Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo
J. Am. Coll. Cardiol., March 15, 2000; 35(4): 1040 - 1047.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
A. Basile-Borgia, J. H Abel, and H. Mahloogi
Molecular advances in cardiac and cardiovascular disease
Perfusion, March 1, 1999; 14(2): 89 - 99.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. P. Kypson, K. Peppel, S. A. Akhter, R. E. Lilly, D. D. Glower, R. J. Lefkowitz, W. J. Koch, and R. W. Anderson
Ex Vivo Adenovirus-Mediated Gene Transfer To The Adult Rat Heart
J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 623 - 630.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Baek and K. L. March
Gene Therapy for Restenosis : Getting Nearer the Heart of the Matter
Circ. Res., February 23, 1998; 82(3): 295 - 305.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. B. DeYoung and D. A. Dichek
Gene Therapy for Restenosis : Are We Ready?
Circ. Res., February 23, 1998; 82(3): 306 - 313.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. J Feldman and G. Steg
Optimal techniques for arterial gene transfer
Cardiovasc Res, September 1, 1997; 35(3): 391 - 404.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Vassalli and D. A Dichek
Gene therapy for arterial thrombosis
Cardiovasc Res, September 1, 1997; 35(3): 459 - 469.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Sawa, K. Kadoba, K. Suzuki, H.-Z. Bai, Y. Kaneda, R. Shirakura, and H. Matsuda
EFFICIENT GENE TRANSFER METHOD INTO THE WHOLE HEART THROUGH THE CORONARY ARTERY WITH HEMAGGLUTINATING VIRUS OF JAPAN LIPOSOME
J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 512 - 519.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Lee, H. Laks, D. C. Drinkwater, A. Blitz, L. Lam, Y. Shiraishi, P. Chang, T. A. Drake, and A. Ardehali
CARDIAC GENE TRANSFER BY INTRACORONARY INFUSION OF ADENOVIRUS VECTOR--MEDIATED REPORTER GENE IN THE TRANSPLANTED MOUSE HEART
J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 246 - 252.
[Abstract] [Full Text]


Home page
CirculationHome page
Y. Sawa, K. Suzuki, H.-Z. Bai, R. Shirakura, R. Morishita, Y. Kaneda, and H. Matsuda
Efficiency of In Vivo Gene Transfection Into Transplanted Rat Heart by Coronary Infusion of HVJ Liposome
Circulation, November 1, 1995; 92(9): 479 - 482.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
R. T. Rowland, J. C. Cleveland Jr, X. Meng, A. H. Harken, and J. M. Brown
Potential Gene Therapy Strategies in the Treatment of Cardiovascular Disease
Ann. Thorac. Surg., September 1, 1995; 60(3): 721 - 728.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
H. Ooboshi, M. J. Welsh, C. D. Rios, B. L. Davidson, and D. D. Heistad
Adenovirus-Mediated Gene Transfer In Vivo to Cerebral Blood Vessels and Perivascular Tissue
Circ. Res., July 1, 1995; 77(1): 7 - 13.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Ardehali, A. Fyfe, H. Laks, D. C. Drinkwater Jr., J.-H. Qiao, and A. J. Lusis
Direct gene transfer into donor hearts at the time of harvest
J. Thorac. Cardiovasc. Surg., April 1, 1995; 109(4): 716 - 720.
[Abstract] [Full Text]


Home page
CirculationHome page
E. G. Nabel
Gene Therapy for Cardiovascular Disease
Circulation, January 15, 1995; 91(2): 541 - 548.
[Full Text]


Home page
CirculationHome page
Y. Taniyama, K. Tachibana, K. Hiraoka, T. Namba, K. Yamasaki, N. Hashiya, M. Aoki, T. Ogihara, K. Yasufumi, and R. Morishita
Local Delivery of Plasmid DNA Into Rat Carotid Artery Using Ultrasound
Circulation, March 12, 2002; 105(10): 1233 - 1239.
[Abstract] [Full Text] [PDF]